Sibutramine cardiovascular outcomes trial scout
2 Sep 2010 … Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects … for the SCOUT Investigators … We enrolled in our study 10,744 overweight or obese subjects, 55 years of age or older, with preexisting…The recent Sibutramine Cardiovascular Outcomes Trial (SCOUT) confirmed that subjects with preexisting cardiovascular disease (CVD) on long-term (5 years)…1 Nov 2005 … The Sibutramine Cardiovascular Outcome Trial (SCOUT) has been designed to determine whether weight management in cardiovascular…heart failure, or cardiac arrhythmias. The recent Sibutramine Cardiovascular Out- comes Trial (SCOUT) confirmed that subjects with preexisting cardiovascular.Official Title: Sibutramine Cardiovascular Morbidity/Mortality Outcomes Study in …. disease in an overweight high risk population from the SCOUT trial.of cardiovascular outcomes among high-risk subjects, the SCOUT. (Sibutramine Cardiovascular Outcome Trial) was designed as a double-blind…22 Dec 2011 … The Sibutramine Cardiovascular OUTcomes (SCOUT) trial was the first prospective trial that attempted to assess the effects of intentional…27 Jan 2009 … … lead‐in period of the sibutramine cardiovascular outcomes trial (SCOUT)* … Main results from the 6‐week lead‐in period of the SCOUT trial…14 May 2015 … The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom. J F Hayes…22 Dec 2011 … Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.